Brazil vs Iran: Mortality from CVD, cancer, diabetes or CRD between exact … female
Mortality from CVD, cancer, diabetes or CRD between exact … female over time
- Brazil
- Iran
How they compare
Iran currently reports 12.7% against 12.0% in Brazil, a difference of 0.7%.
That makes Iran's figure about 1.1 times Brazil's.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Brazil ahead.
Brazil ranks 128th and Iran ranks 125th of 185 countries.
Across the 3 decades both report, Brazil averaged higher in 2 and Iran in 1.
Head to head by decade
| Decade | Brazil | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.7% | 13.8% | 1.9% | Brazil |
| 2010s | 13.3% | 12.0% | 1.3% | Brazil |
| 2020s | 12.0% | 12.1% | 0.1% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Brazil or Iran?
- Iran, at 12.7% against 12.0% in Brazil as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Brazil and Iran?
- 0.7%, with Iran ahead.
- How many years of comparable data are there for Brazil and Iran?
- 22 years are reported by both, from 2000 to 2021.
- How do Brazil and Iran rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Brazil ranks 128th and Iran ranks 125th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).